Screening for congenital hypothyroidism by using cord blood thyroid stimulating hormone (CBTSH) levels in neonates

Laxmi Gudaganatti1, Sangamma G Sajjan1, Romana Khursheed2

  • 1Department of Biochemistry, KAHER, J.N. Medical College, Belagavi, Karnataka, India.

Insights

Newborn screening for congenital hypothyroidism (CH) is vital. This study found that maternal complications and certain neonatal factors, like prematurity, are linked to higher cord blood Thyroid-Stimulating Hormone (TSH) levels, aiding early CH detection.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Public Health

Background:

  • Congenital hypothyroidism (CH) is a leading preventable cause of intellectual disability in children.
  • Early detection through newborn screening is crucial to prevent severe developmental outcomes.
  • Thyroid-Stimulating Hormone (TSH) screening in cord blood is a key method for identifying CH.

Purpose of the Study:

  • To assess the incidence of CH using cord blood TSH (CBTSH) levels.
  • To investigate the impact of maternal and perinatal factors on CBTSH levels.

Main Methods:

  • A cross-sectional study involving 106 neonates in urban south Karnataka, India.
  • Umbilical cord blood samples were analyzed for CBTSH using electrochemiluminescence.
  • Statistical analysis was performed to determine associations.

Main Results:

  • The mean CBTSH level was 6.20 ± 5.90 μIU/ml.
  • Significant associations were found between CBTSH levels and maternal complications (age, delivery mode, gravida, prenatal hypothyroidism).
  • Higher CBTSH levels were observed in preterm infants, those with Apgar scores <7, vaginal deliveries, primigravida mothers, males, and low-birth-weight neonates.

Conclusions:

  • Maternal health issues significantly correlate with CBTSH levels.
  • Specific neonatal characteristics, including prematurity and low birth weight, are associated with elevated CBTSH, highlighting risk factors for CH.
Abstract